Because Bromodomain and extra-terminal domain (BET) proteins regulate an array of cancer-associated genes and pathways, pharmacological inhibition of BET proteins using inhibitors (BETi) has emerged as an anti-inflammatory and anti-cancer epigenetic therapeutic modality (20). This evidence concerns the gene DNER and cancer.